Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	Pyrin domain binding	NLRP2 PYCARD	1.14e-04	3	124	2	GO:0032090
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	PKD1L2 PKDREJ RYR1 SLC30A6 NALCN SLC22A1 SCN5A TRPM8 GRIN3A SLC4A4 SLC4A9	1.54e-04	465	124	11	GO:0046873
GeneOntologyMolecularFunction	ubiquitin-like ligase-substrate adaptor activity	DCAF1 PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	1.59e-04	82	124	5	GO:1990756
GeneOntologyMolecularFunction	enzyme-substrate adaptor activity	DCAF1 PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	3.16e-04	95	124	5	GO:0140767
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	3.78e-04	55	124	4	GO:0042974
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	PKD1L2 PKDREJ RYR1 SLC30A6 NALCN SLC15A2 SLC22A1 SCN5A TMC8 TMEM150C TRPM8 GRIN3A SLC4A4 SLC4A9	4.12e-04	793	124	14	GO:0015075
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	PKD1L2 PKDREJ RYR1 SLC30A6 NALCN SLC15A2 SLC22A1 SCN5A TRPM8 GRIN3A SLC4A4 SLC4A9	5.36e-04	627	124	12	GO:0022890
GeneOntologyMolecularFunction	sodium:bicarbonate symporter activity	SLC4A4 SLC4A9	5.65e-04	6	124	2	GO:0008510
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	PKD1L2 PKDREJ RYR1 SLC30A6 NALCN SLC15A2 SLC22A1 SCN5A TRPM8 GRIN3A SLC4A4 SLC4A9	8.85e-04	664	124	12	GO:0008324
GeneOntologyBiologicalProcess	brainstem development	NLGN4Y NLGN4X SCN5A	1.16e-05	8	124	3	GO:0003360
GeneOntologyCellularComponent	Cul2-RING ubiquitin ligase complex	PRAMEF5 PRAMEF4 ARIH1 PRAMEF11 PRAMEF6	9.56e-06	47	127	5	GO:0031462
GeneOntologyCellularComponent	cullin-RING ubiquitin ligase complex	DCAF1 CUL4A PRAMEF5 FBXL17 PRAMEF4 ARIH1 PRAMEF11 PRAMEF6	4.68e-05	212	127	8	GO:0031461
GeneOntologyCellularComponent	ubiquitin ligase complex	DCAF1 CUL4A PRAMEF5 FBXL17 PRAMEF4 MEGF8 ABTB1 ARIH1 PRAMEF11 PRAMEF6	5.90e-05	352	127	10	GO:0000151
GeneOntologyCellularComponent	symmetric, GABA-ergic, inhibitory synapse	NLGN4Y NLGN4X	2.18e-04	4	127	2	GO:0098983
GeneOntologyCellularComponent	asymmetric, glutamatergic, excitatory synapse	NLGN4Y NLGN4X PLXNC1	4.04e-04	24	127	3	GO:0098985
Domain	ARM-type_fold	DCAF1 RALGAPA1 CLASP1 NEK10 UBR4 RALGAPA2 RANBP17 THADA ELMO2 NBEAL2 WDFY3 TARBP1	2.72e-06	339	124	12	IPR016024
Domain	Transform_prot_C-ets	ETS1 ETS2	4.37e-05	2	124	2	IPR016311
Domain	NLGN4	NLGN4Y NLGN4X	4.37e-05	2	124	2	IPR030025
Domain	-	PRAMEF5 FBXL17 LRRK1 PRAMEF4 NLRP2 OMG LRIG3 LRRC53 LRRC37B PRAMEF6	5.66e-05	321	124	10	3.80.10.10
Domain	L_dom-like	PRAMEF5 FBXL17 LRRK1 PRAMEF4 NLRP2 OMG LRIG3 LRRC53 LRRC37B PRAMEF6	6.77e-05	328	124	10	IPR032675
Domain	ARM-like	DCAF1 CLASP1 NEK10 RANBP17 ELMO2 NBEAL2 WDFY3 TARBP1 HOMEZ	8.05e-05	270	124	9	IPR011989
Domain	LH2	PKD1L2 PKDREJ ALOXE3	2.17e-04	18	124	3	SM00308
Domain	PRAME_family	PRAMEF5 PRAMEF4 PRAMEF6	2.56e-04	19	124	3	IPR026271
Domain	REJ	PKD1L2 PKDREJ	2.60e-04	4	124	2	PS51111
Domain	REJ_dom	PKD1L2 PKDREJ	2.60e-04	4	124	2	IPR014010
Domain	-	PKD1L2 PKDREJ ALOXE3	3.48e-04	21	124	3	2.60.60.20
Domain	PLAT	PKD1L2 PKDREJ ALOXE3	3.48e-04	21	124	3	PF01477
Domain	PLAT/LH2_dom	PKD1L2 PKDREJ ALOXE3	3.48e-04	21	124	3	IPR001024
Domain	PLAT	PKD1L2 PKDREJ ALOXE3	3.48e-04	21	124	3	PS50095
Domain	Na/HCO3_transpt	SLC4A4 SLC4A9	4.32e-04	5	124	2	IPR003024
Domain	Nlgn	NLGN4Y NLGN4X	4.32e-04	5	124	2	IPR000460
Domain	PKD_2	PKD1L2 PKDREJ	4.32e-04	5	124	2	IPR003915
Domain	DUF4704	NBEAL2 WDFY3	4.32e-04	5	124	2	IPR031570
Domain	DUF4704	NBEAL2 WDFY3	4.32e-04	5	124	2	PF15787
Domain	PH_BEACH	NBEAL2 WDFY3	6.45e-04	6	124	2	PF14844
Domain	PKD/REJ-like	PKD1L2 PKDREJ	6.45e-04	6	124	2	IPR002859
Domain	Alpha/beta_knot_MTases	SLC15A2 TARBP1	6.45e-04	6	124	2	IPR029028
Domain	REJ	PKD1L2 PKDREJ	6.45e-04	6	124	2	PF02010
Domain	ETS_DOMAIN_1	ETS1 ETS2 ELF4	8.29e-04	28	124	3	PS00345
Domain	ETS_DOMAIN_2	ETS1 ETS2 ELF4	8.29e-04	28	124	3	PS00346
Domain	Ets	ETS1 ETS2 ELF4	8.29e-04	28	124	3	PF00178
Domain	ETS	ETS1 ETS2 ELF4	8.29e-04	28	124	3	SM00413
Domain	Ets_dom	ETS1 ETS2 ELF4	8.29e-04	28	124	3	IPR000418
Domain	ETS_DOMAIN_3	ETS1 ETS2 ELF4	8.29e-04	28	124	3	PS50061
Domain	PH-BEACH_dom	NBEAL2 WDFY3	1.19e-03	8	124	2	IPR023362
Domain	-	NBEAL2 WDFY3	1.19e-03	8	124	2	2.30.29.40
Domain	PH_BEACH	NBEAL2 WDFY3	1.19e-03	8	124	2	PS51783
Domain	Plexin_repeat	SEMA4B MEGF8 PLXNC1	1.23e-03	32	124	3	IPR002165
Domain	PSI	SEMA4B MEGF8 PLXNC1	1.23e-03	32	124	3	PF01437
Domain	-	SLC4A4 SLC4A9	1.53e-03	9	124	2	3.40.1100.10
Domain	BEACH	NBEAL2 WDFY3	1.53e-03	9	124	2	PS50197
Domain	Beach	NBEAL2 WDFY3	1.53e-03	9	124	2	PF02138
Domain	-	NBEAL2 WDFY3	1.53e-03	9	124	2	1.10.1540.10
Domain	Beach	NBEAL2 WDFY3	1.53e-03	9	124	2	SM01026
Domain	Band3_cytoplasmic_dom	SLC4A4 SLC4A9	1.53e-03	9	124	2	IPR013769
Domain	Band_3_cyto	SLC4A4 SLC4A9	1.53e-03	9	124	2	PF07565
Domain	BEACH_dom	NBEAL2 WDFY3	1.53e-03	9	124	2	IPR000409
Domain	PTrfase/Anion_transptr	SLC4A4 SLC4A9	1.90e-03	10	124	2	IPR016152
Domain	Rap_GAP	RALGAPA1 RALGAPA2	1.90e-03	10	124	2	PF02145
Domain	HCO3_transpt_euk	SLC4A4 SLC4A9	1.90e-03	10	124	2	IPR003020
Domain	HCO3_cotransp	SLC4A4 SLC4A9	1.90e-03	10	124	2	PF00955
Domain	HCO3_transpt_C	SLC4A4 SLC4A9	1.90e-03	10	124	2	IPR011531
Domain	MFS_dom	MFSD6 SLC29A2 SLC15A2 CLN3 SLC22A1	2.01e-03	134	124	5	IPR020846
Domain	Leu-rich_rpt	FBXL17 LRRK1 NLRP2 OMG LRIG3 LRRC53 LRRC37B	2.23e-03	271	124	7	IPR001611
Domain	Rap_GAP_dom	RALGAPA1 RALGAPA2	2.31e-03	11	124	2	IPR000331
Domain	PNT	ETS1 ETS2	2.31e-03	11	124	2	PS51433
Domain	SAM_PNT	ETS1 ETS2	2.31e-03	11	124	2	PF02198
Domain	RAPGAP	RALGAPA1 RALGAPA2	2.31e-03	11	124	2	PS50085
Domain	PKD_channel	PKD1L2 PKDREJ	2.31e-03	11	124	2	PF08016
Domain	Pointed_dom	ETS1 ETS2	2.31e-03	11	124	2	IPR003118
Domain	PKD1_2_channel	PKD1L2 PKDREJ	2.31e-03	11	124	2	IPR013122
Domain	SAM_PNT	ETS1 ETS2	2.31e-03	11	124	2	SM00251
Domain	PSI	SEMA4B MEGF8 PLXNC1	3.10e-03	44	124	3	IPR016201
Domain	Carboxylesterase_B_CS	NLGN4Y NLGN4X	3.25e-03	13	124	2	IPR019819
Domain	PSI	SEMA4B MEGF8 PLXNC1	3.52e-03	46	124	3	SM00423
Domain	-	DCAF1 CLASP1 NEK10 RANBP17 ELMO2 WDFY3	3.68e-03	222	124	6	1.25.10.10
Domain	CARBOXYLESTERASE_B_2	NLGN4Y NLGN4X	3.78e-03	14	124	2	PS00941
Domain	COesterase	NLGN4Y NLGN4X	3.78e-03	14	124	2	PF00135
Domain	CarbesteraseB	NLGN4Y NLGN4X	3.78e-03	14	124	2	IPR002018
Domain	LRR_TYP	LRRK1 OMG LRIG3 LRRC53 LRRC37B	6.57e-03	177	124	5	SM00369
Domain	Leu-rich_rpt_typical-subtyp	LRRK1 OMG LRIG3 LRRC53 LRRC37B	6.57e-03	177	124	5	IPR003591
Pathway	KEGG_DORSO_VENTRAL_AXIS_FORMATION	ETS1 ETS2 PIWIL4 SOS1	1.56e-05	24	91	4	M11190
Pubmed	Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice.	PRAMEF5 PRAMEF4 PKD1L2 NLRP2 PRAMEF11 PRAMEF6	1.34e-09	30	130	6	38786026
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SEMA4B UBR4 HECTD4 LRRK1 RALGAPA2 SLC29A2 RYR1 FANCA THADA IGF2R MDN1 SHANK2 MEGF8 PLA2G4B CLN3 NBEAL2 SCN5A SEC16A WDFY3 ESPL1	5.68e-09	1105	130	20	35748872
Pubmed	Differences in gene expression between mouse and human for dynamically regulated genes in early embryo.	PRAMEF5 PRAMEF4 NLRP2 PRAMEF11 PRAMEF6	6.19e-08	28	130	5	25089626
Pubmed	Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	4.27e-07	17	130	4	23565261
Pubmed	Mouse Pramel1 regulates spermatogonial development by inhibiting retinoic acid signaling during spermatogenesis.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	4.27e-07	17	130	4	37781892
Pubmed	The promoter of the oocyte-specific gene, Oog1, functions in both male and female meiotic germ cells in transgenic mice.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	5.48e-07	18	130	4	23894331
Pubmed	Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	5.48e-07	18	130	4	39181896
Pubmed	Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	5.48e-07	18	130	4	12890732
Pubmed	Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	5.48e-07	18	130	4	29731491
Pubmed	Identification of a new expanding family of genes characterized by atypical LRR domains. Localization of a cluster preferentially expressed in oocyte.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	5.48e-07	18	130	4	14675769
Pubmed	Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	6.92e-07	19	130	4	28604677
Pubmed	Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	8.62e-07	20	130	4	26694250
Pubmed	Oog1, an oocyte-specific protein, interacts with Ras and Ras-signaling proteins during early embryogenesis.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	8.62e-07	20	130	4	16580637
Pubmed	Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	8.62e-07	20	130	4	21425410
Pubmed	CRL4-DDB1-VPRBP ubiquitin ligase mediates the stress triggered proteolysis of Mcm10.	DCAF1 CUL4A MCM10	1.01e-06	6	130	3	22570418
Pubmed	Nbeal2 interacts with Dock7, Sec16a, and Vac14.	NBEAL2 SEC16A DOCK7	1.01e-06	6	130	3	29187380
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	TMPPE PRAMEF5 HECTD4 ETS1 PRAMEF4 RALGAPA2 MDN1 GLIS2 PRAMEF11 PRAMEF6	1.19e-06	363	130	10	14691545
Pubmed	Sertoli cell-only phenotype and scRNA-seq define PRAMEF12 as a factor essential for spermatogenesis in mice.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	1.29e-06	22	130	4	31729367
Pubmed	Oogenesis specific genes (Nobox, Oct4, Bmp15, Gdf9, Oogenesin1 and Oogenesin2) are differentially expressed during natural and gonadotropin-induced mouse follicular development.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	1.56e-06	23	130	4	19480014
Pubmed	Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	2.22e-06	25	130	4	12620990
Pubmed	MAGE-B4, a binding partner of PRAMEF12, is dispensable for spermatogenesis and male fertility in mice.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	2.22e-06	25	130	4	37451217
Pubmed	Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	2.61e-06	26	130	4	18500982
Pubmed	An abundance of X-linked genes expressed in spermatogonia.	PRAMEF5 PRAMEF4 STK31 PRAMEF11 PRAMEF6	2.88e-06	59	130	5	11279525
Pubmed	Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation.	DCAF1 CUL4A UBR4	4.22e-06	9	130	3	17855541
Pubmed	LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	6.18e-06	32	130	4	37889087
Pubmed	Behavioral phenotypes of genetic mouse models of autism.	NLGN4Y SHANK2 NLGN4X	8.24e-06	11	130	3	26403076
Pubmed	Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	8.92e-06	35	130	4	19389355
Pubmed	Cutting edge: Endoplasmic reticulum stress licenses macrophages to produce mature IL-1β in response to TLR4 stimulation through a caspase-8- and TRIF-dependent pathway.	XBP1 TICAM2 PYCARD	1.10e-05	12	130	3	24489101
Pubmed	Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family.	ETS1 ETS2	1.39e-05	2	130	2	17986575
Pubmed	ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm.	ETS1 ETS2	1.39e-05	2	130	2	18958307
Pubmed	Ets-1 and Ets-2 protooncogene expression in theca cells of the adult mouse ovary.	ETS1 ETS2	1.39e-05	2	130	2	1511734
Pubmed	Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.	NLGN4Y NLGN4X	1.39e-05	2	130	2	23183221
Pubmed	Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism.	NLGN4Y NLGN4X	1.39e-05	2	130	2	24855039
Pubmed	Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder.	NLGN4Y NLGN4X	1.39e-05	2	130	2	37001827
Pubmed	c-ETS transcription factors play an essential role in the licensing of human MCM4 origin of replication.	ETS1 ETS2	1.39e-05	2	130	2	26365772
Pubmed	Unspliced XBP1 contributes to cholesterol biosynthesis and tumorigenesis by stabilizing SREBP2 in hepatocellular carcinoma.	SREBF2 XBP1	1.39e-05	2	130	2	35933495
Pubmed	An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4 integrin gene promoter.	ETS1 ETS2	1.39e-05	2	130	2	8195215
Pubmed	The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: both loci are transcriptionally active.	ETS1 ETS2	1.39e-05	2	130	2	2997781
Pubmed	Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis.	ETS1 ETS2	1.39e-05	2	130	2	8183549
Pubmed	Transcription factor Ets1, but not the closely related factor Ets2, inhibits antibody-secreting cell differentiation.	ETS1 ETS2	1.39e-05	2	130	2	24277931
Pubmed	The Ets family of proteins: weak modulators of gene expression in quest for transcriptional partners.	ETS1 ETS2	1.39e-05	2	130	2	8519813
Pubmed	Unusually rapid evolution of Neuroligin-4 in mice.	NLGN4Y NLGN4X	1.39e-05	2	130	2	18434543
Pubmed	Characterization and localization of the products of the human homologs of the v-ets oncogene.	ETS1 ETS2	1.39e-05	2	130	2	3285299
Pubmed	Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice.	NLGN4Y NLGN4X	1.39e-05	2	130	2	37080762
Pubmed	Mammalian ets-1 and ets-2 genes encode highly conserved proteins.	ETS1 ETS2	1.39e-05	2	130	2	2847145
Pubmed	Autism Related Neuroligin-4 Knockout Impairs Intracortical Processing but not Sensory Inputs in Mouse Barrel Cortex.	NLGN4Y NLGN4X	1.39e-05	2	130	2	29106499
Pubmed	Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.	NLGN4Y NLGN4X	1.39e-05	2	130	2	26456829
Pubmed	Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro.	NLGN4Y NLGN4X	1.39e-05	2	130	2	24104404
Pubmed	The avian and mammalian ets genes: molecular characterization, chromosome mapping, and implication in human leukemia.	ETS1 ETS2	1.39e-05	2	130	2	3019221
Pubmed	A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y.	NLGN4Y NLGN4X	1.39e-05	2	130	2	32243781
Pubmed	Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4.	NLGN4Y NLGN4X	1.39e-05	2	130	2	22989184
Pubmed	In vivo modulation of ETS genes induced by electromagnetic fields.	ETS1 ETS2	1.39e-05	2	130	2	11887334
Pubmed	Advancing the understanding of autism disease mechanisms through genetics.	NLGN4Y SHANK2 NLGN4X	1.42e-05	13	130	3	27050589
Pubmed	Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.	ETS1 ETS2 ELF4	1.80e-05	14	130	3	14635793
Pubmed	Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	2.69e-05	46	130	4	17287250
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	CLASP1 UBR4 SREBF2 XBP1 PKD1L2 MTNR1A SLC4A4 ESPL1	3.02e-05	322	130	8	26514267
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	3.76e-05	50	130	4	31806660
Pubmed	Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor.	CUL4A ETS1 ETS2	4.00e-05	18	130	3	25117710
Pubmed	Physical interaction and functional synergy between glucocorticoid receptor and Ets2 proteins for transcription activation of the rat cytochrome P-450c27 promoter.	ETS1 ETS2	4.15e-05	3	130	2	11279115
Pubmed	Multifaceted activity of HIV Vpr/Vpx proteins: the current view of their virological functions.	DCAF1 CUL4A	4.15e-05	3	130	2	20069611
Pubmed	Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells.	ETS1 ETS2	4.15e-05	3	130	2	20671229
Pubmed	Sp100 interacts with ETS-1 and stimulates its transcriptional activity.	ETS1 ETS2	4.15e-05	3	130	2	11909962
Pubmed	Inhibition of basal activity of c-jun-NH2-terminal kinase (JNK) represses the expression of presenilin-1 by a p53-dependent mechanism.	ETS1 ETS2	4.15e-05	3	130	2	18374905
Pubmed	An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.	ETS1 ETS2	4.15e-05	3	130	2	1409581
Pubmed	A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.	ETS1 ETS2	4.15e-05	3	130	2	8871649
Pubmed	The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation.	ETS1 ETS2	4.15e-05	3	130	2	7689222
Pubmed	Transcription factors Ets1, Ets2, and Elf1 exhibit differential localization in human endometrium across the menstrual cycle and alternate isoforms in cultured endometrial cells.	ETS1 ETS2	4.15e-05	3	130	2	10377039
Pubmed	Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage.	ETS1 ETS2	4.15e-05	3	130	2	10375504
Pubmed	Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress.	ETS1 XBP1	4.15e-05	3	130	2	21423203
Pubmed	Tuberous sclerosis tumor suppressor complex-like complexes act as GTPase-activating proteins for Ral GTPases.	RALGAPA1 RALGAPA2	4.15e-05	3	130	2	19520869
Pubmed	Evolution of the Autism-Associated Neuroligin-4 Gene Reveals Broad Erosion of Pseudoautosomal Regions in Rodents.	NLGN4Y NLGN4X	4.15e-05	3	130	2	32011705
Pubmed	Conserved chromosomal positions of dual domains of the ets protooncogene in cats, mice, and humans.	ETS1 ETS2	4.15e-05	3	130	2	3513188
Pubmed	HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase.	DCAF1 CUL4A	4.15e-05	3	130	2	17314515
Pubmed	Analysis of gene networks in white adipose tissue development reveals a role for ETS2 in adipogenesis.	ETS1 ETS2	4.15e-05	3	130	2	21989915
Pubmed	The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation.	NLRP2 PYCARD	4.15e-05	3	130	2	11250163
Pubmed	Analysis of the neuroligin 4Y gene in patients with autism.	NLGN4Y NLGN4X	4.15e-05	3	130	2	18628683
Pubmed	HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase.	DCAF1 CUL4A	4.15e-05	3	130	2	19667756
Pubmed	Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.	ETS1 ETS2	4.15e-05	3	130	2	7609063
Pubmed	HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.	DCAF1 CUL4A	4.15e-05	3	130	2	17630831
Pubmed	Regulation of the human interleukin-5 promoter by Ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1.	ETS1 ETS2	4.15e-05	3	130	2	10212281
Pubmed	Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina.	NLGN4Y NLGN4X	4.15e-05	3	130	2	21282647
Pubmed	Sequence-specific DNA binding of the proto-oncoprotein ets-1 defines a transcriptional activator sequence within the long terminal repeat of the Moloney murine sarcoma virus.	ETS1 ETS2	4.15e-05	3	130	2	2163347
Pubmed	MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation.	ETS1 ETS2	4.15e-05	3	130	2	24968297
Pubmed	Involvement of the proto-oncogene c-ets 1 and the urokinase plasminogen activator during mouse implantation and placentation.	VWF ETS1	4.15e-05	3	130	2	8179996
Pubmed	HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest.	DCAF1 MCM10	4.15e-05	3	130	2	26032416
Pubmed	Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2.	ETS1 ETS2	4.15e-05	3	130	2	28119415
Pubmed	ZAR1 and ZAR2 are required for oocyte meiotic maturation by regulating the maternal transcriptome and mRNA translational activation.	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	6.76e-05	58	130	4	31598710
Pubmed	Diverse functions of myosin VI elucidated by an isoform-specific α-helix domain.	DCAF1 SEC16A DOCK7	7.46e-05	22	130	3	26950368
Pubmed	Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection.	DCAF1 CUL4A	8.28e-05	4	130	2	18464893
Pubmed	The HIV1 protein Vpr acts to promote G2 cell cycle arrest by engaging a DDB1 and Cullin4A-containing ubiquitin ligase complex using VprBP/DCAF1 as an adaptor.	DCAF1 CUL4A	8.28e-05	4	130	2	17620334
Pubmed	IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells.	ETS1 ETS2	8.28e-05	4	130	2	10815800
Pubmed	DCAF1 (VprBP): emerging physiological roles for a unique dual-service E3 ubiquitin ligase substrate receptor.	DCAF1 CUL4A	8.28e-05	4	130	2	30590706
Pubmed	Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates.	DCAF1 CUL4A	8.28e-05	4	130	2	21957298
Pubmed	Transcriptional regulation of the apolipoprotein F (ApoF) gene by ETS and C/EBPα in hepatoma cells.	ETS1 ETS2	8.28e-05	4	130	2	25726912
Pubmed	Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1).	NEDD9 SOS1	8.28e-05	4	130	2	9162067
Pubmed	The SAM domain of human TEL2 can abrogate transcriptional output from TEL1 (ETV-6) and ETS1/ETS2.	ETS1 ETS2	8.28e-05	4	130	2	22615925
Pubmed	Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.	ETS1 ETS2	8.28e-05	4	130	2	26389665
Pubmed	Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.	ETS1 ETS2	8.28e-05	4	130	2	10918595
Pubmed	Regulation of CSF-1 receptor expression.	ETS1 ETS2	8.28e-05	4	130	2	8981363
Pubmed	An evolutionarily conserved NPC subcomplex, which redistributes in part to kinetochores in mammalian cells.	NUP98 NUP133	8.28e-05	4	130	2	11564755
Cytoband	1p36.21	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	3.21e-05	63	130	4	1p36.21
GeneFamily	PRAME family	PRAMEF5 PRAMEF4 PRAMEF11 PRAMEF6	5.17e-06	24	88	4	686
GeneFamily	ETS transcription factor family	ETS1 ETS2 ELF4	3.34e-04	28	88	3	534
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEAL2 WDFY3	8.25e-04	9	88	2	1230
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN4Y DNER RANBP17 SHANK2 TMEM150C EEF1AKMT2 RP1	5.17e-07	164	129	7	1cb5fbd7050650047ad6f2ca792118e98d58d22b
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SEMA4B SREBF2 USP44 LRIG3 SHANK2 SLC4A4	1.26e-05	176	129	6	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	moderate-Myeloid-Neutrophil\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GPR65 ETS2 IFITM1 HCAR3 PLXNC1 ABTB1	2.06e-05	192	129	6	8105408400dac5dcb0ce62b558433257559c9f09
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NEK10 SHANK2 KITLG NBEAL2 KDM7A VWA5B1	2.18e-05	194	129	6	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NEK10 SHANK2 KITLG NBEAL2 KDM7A VWA5B1	2.18e-05	194	129	6	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SREBF2 XBP1 SHANK2 SLC15A2 TMEM150C SLC4A4	2.44e-05	198	129	6	6ba5e5970109a04ed968bac7ff099ae250c579dc
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NCKAP1 XBP1 RANBP17 LRIG3 SLC15A2 SLC4A4	2.51e-05	199	129	6	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ETS2 IFITM1 RYR1 NEDD9 HCAR3 SLC4A4	2.59e-05	200	129	6	41705bbba40eb5ddca0b223191aac1bce00163b8
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IFITM1 RALGAPA2 IGF2R PLXNC1 ABTB1 WDFY3	2.59e-05	200	129	6	6beabd5bad042d4d65c89c2f537c7376230f7c08
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SREBF2 XBP1 RALGAPA2 RANBP17 LRIG3 SHANK2	2.59e-05	200	129	6	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Parenchyma_COVID-19-Epithelial-TX-Basal_3\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	ETS2 IFITM1 RYR1 NEDD9 HCAR3 SLC4A4	2.59e-05	200	129	6	53e04399d0308b40ae99fbfaa4ff62bf061822d8
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ETS2 IFITM1 RYR1 NEDD9 HCAR3 SLC4A4	2.59e-05	200	129	6	cc8df398532c9324fd3e171000b1ea5c208cd691
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IFITM1 RALGAPA2 IGF2R PLXNC1 ABTB1 WDFY3	2.59e-05	200	129	6	026495aa7f1e7528a01d9199475cfc393677fc60
Drug	AC1L1FET	GBA3 KITLG GLCE ELF4	6.25e-06	22	127	4	CID000003205
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A	CUL4A HECTD4 NUP98 KRIT1 SHANK2 SLC15A2 CENPI ESPL1	9.60e-06	185	127	8	4755_DN
Drug	m-7a	RYR1 GBA3 ELF4	1.39e-05	9	127	3	CID000029558
Drug	Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; PC3; HG-U133A	CUL4A NCKAP1 NUP98 ETS2 KRIT1 CENPI SLC4A4 TARBP1	1.41e-05	195	127	8	1944_UP
Drug	Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; HL60; HG-U133A	ETS2 FPGT SLC29A2 OMG KRIT1 IGF2R MDN1 ELMO2	1.57e-05	198	127	8	1975_UP
Drug	Clopamide [636-54-4]; Up 200; 11.6uM; HL60; HG-U133A	OMG FANCA TAS2R1 NBEAL2 SCN5A ALOXE3 KDM7A SLC4A4	1.63e-05	199	127	8	1605_UP
Disease	X-11261 measurement	IGF2R SLC22A1	4.83e-05	3	119	2	EFO_0021221
Disease	X-24422 measurement	IGF2R SLC22A1	4.83e-05	3	119	2	EFO_0800880
Disease	cation-independent mannose-6-phosphate receptor measurement	IGF2R SLC22A1	9.63e-05	4	119	2	EFO_0008075
Disease	urate measurement, bone density	DNER ETS1 ETS2 DNAH14 FANCA NEDD9 RANBP17 PLXNC1 GLIS2 SEC16A	2.11e-04	619	119	10	EFO_0003923, EFO_0004531
Disease	Autism spectrum disorder	SHANK2 NLGN4X	3.34e-04	7	119	2	cv:C1510586
Disease	acisoga measurement	IGF2R SLC22A1	3.34e-04	7	119	2	EFO_0800068
Disease	argininate measurement	IGF2R SLC22A1	4.44e-04	8	119	2	EFO_0800055
Disease	pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) measurement	IGF2R SLC22A1	4.44e-04	8	119	2	EFO_0800494
Disease	survival time	MCM10 CYP39A1	5.70e-04	9	119	2	EFO_0000714
Disease	X-11381 measurement	IGF2R SLC22A1	5.70e-04	9	119	2	EFO_0021228
Disease	response to angiotensin-converting enzyme inhibitor, Cough	CLASP1 PKD1L2 NEDD9	8.55e-04	46	119	3	EFO_0005325, HP_0012735
Disease	diastolic blood pressure, systolic blood pressure	MTERF1 NEK10 FBXL17 SYT10 LRIG3 PLXNC1 SCN5A SEC16A SLC35E3	1.61e-03	670	119	9	EFO_0006335, EFO_0006336
Disease	Proteinuria	VWF FAM151B	1.64e-03	15	119	2	HP_0000093
Disease	anemia (implicated_via_orthology)	SLC4A4 SLC4A9	1.64e-03	15	119	2	DOID:2355 (implicated_via_orthology)
Disease	neutrophil count, eosinophil count	HECTD4 ETS1 THADA KITLG ZNF292	1.75e-03	213	119	5	EFO_0004833, EFO_0004842
Disease	neutrophil count, basophil count	HECTD4 ETS1 THADA KITLG ZNF292	2.18e-03	224	119	5	EFO_0004833, EFO_0005090
Disease	ulcerative colitis	RNF186 GPR65 UBR4 ETS1 FBXL17 EEF1AKMT2	2.43e-03	335	119	6	EFO_0000729
Disease	factor VIII measurement, Ischemic stroke	VWF HECTD4	2.64e-03	19	119	2	EFO_0004630, HP_0002140
Disease	autism spectrum disorder (implicated_via_orthology)	NLGN4Y SHANK2 NLGN4X WDFY3	3.40e-03	152	119	4	DOID:0060041 (implicated_via_orthology)
Disease	granulocyte count	HECTD4 ETS1 THADA KITLG ZNF292	3.74e-03	254	119	5	EFO_0007987

Protein segments in the cluster

Peptide	Gene	Start	Entry
TELAFESQLWLCVQL	ARSF	181	P54793
WTCKDLLLQALRESQ	PYCARD	171	Q9ULZ3
IQLACLGLLWIIKST	SLC4A9	891	Q96Q91
LNECSWSLNILAINK	NEDD9	506	Q14511
WKEQTLLCLLQLIHL	DEPDC4	236	Q8N2C3
ICALFTLVTVLLWNK	GLCE	16	O94923
LQLCALTQAVSKLWV	AMN	11	Q9BXJ7
CNEKIELAILWFLDQ	RANBP17	541	Q9H2T7
LLKLSCTDTTINEWL	OR5I1	186	Q13606
LITNSFVECNRLLKW	ARIH1	261	Q9Y4X5
LEILCKALQRDNWSS	NUP133	1071	Q8WUM0
CVQLLLQLISIACNW	DCAF1	596	Q9Y4B6
DCKWNTLSITDDLLL	DGKK	376	Q5KSL6
INVCSQLDWKRSLAI	NUP98	1416	P52948
LSVLKLACADTWLNQ	OR2A14	181	Q96R47
AICWFVAKNLLETLK	KDM7A	401	Q6ZMT4
QCQILLEQLSWLLQC	MDN1	4296	Q9NU22
NIIFCDLKSDNILVW	LRRK1	1381	Q38SD2
LNTSSLLCDCQLKWL	LRIG3	441	Q6UXM1
LWEFLLALLQDRNTC	ELF4	211	Q99607
EVNISCNNLLLFWLV	ALOXE3	631	Q9BYJ1
LILLSLDKNQWSCTC	LRRC53	206	A6NM62
CTRIWSKENLLALNT	ATXN8OS	136	P0DMR3
QKASLWKLDLCTTVL	KATNB1	546	Q9BVA0
QLWQFLLELLTDKSC	ETS1	336	P14921
ITCKALYTLNEDWLL	PLXNC1	1176	O60486
FTEERLWKIFIQLCL	NEK10	626	Q6ZWH5
WQFLLELLSDKSCQS	ETS2	366	P15036
ALVRQSCSQLLWLLK	FAM151B	206	Q6UXP7
LFLSLCVLLWKAKQA	MEGF8	2661	Q7Z7M0
CNLITKLSLGTFQAW	LRRC37B	636	Q96QE4
FTIWICSENLSLQLK	KRIT1	461	O00522
ECKLQTLVLWNCDIT	NLRP2	896	Q9NX02
SIWKLNDLRDLTQCV	MCM10	316	Q7L590
SCFTNLWALINEALL	PLA2G4B	396	P0C869
RWAKCNQLFELLQDL	GLIS2	171	Q9BZE0
WQVCKELQSSSLSLL	HECTD4	3656	Q9Y4D8
QAFNFWDLIKLLCSV	MFSD6	431	Q6ZSS7
RLFLLWLQALQTNCA	RALGAPA2	131	Q2PPJ7
CWLNENFRIELKALL	GPR83	346	Q9NYM4
NLWKLALQSSSCLSL	NCKAP1	281	Q9Y2A7
FCSKWNLLELAIILA	PKD1L2	2216	Q7Z442
SLLLCQEDWNITDFL	GRIN3A	266	Q8TCU5
ILSVLKLACADTWLN	OR2A5	181	Q96R48
LNSNVLLWITALAIK	NLGN4Y	21	Q8NFZ3
KKWQLIIQLFATCFL	B3GNT5	11	Q9BYG0
LSKQFVQWDELLCQL	DCTN3	161	O75935
KQLQLPDTLSSLLCW	ATP11AUN	81	Q6ZP68
DKAQALLWLYICTLE	ESPL1	676	Q14674
CLLWVLKNADETVLQ	DOCK7	1331	Q96N67
KWFTDLSVLQLNRLL	DOCK7	1346	Q96N67
TLQQKVFILFLTLWL	GCNT4	11	Q9P109
DLNCLSDLLKSSIQW	GCNT4	206	Q9P109
LDKVNLQVYCAWSLL	GBA3	406	Q9H227
EELFGICIQLLNKTW	ELMO2	446	Q96JJ3
FFLITSCNWTKEELL	EEF1AKMT2	186	Q5JPI9
KNLSSLNLCLNWIIN	FBXL17	566	Q9UF56
FCQELWKIQSSLLLE	FANCA	166	O15360
LDSVLFLKKINTCWQ	CUL4A	126	Q13619
FSLLCKSLLSNVSQW	DNAH14	2901	Q0VDD8
EFCLAVLTAVLQWKQ	MS4A6E	131	Q96DS6
LCNIWDNTLLQLVLV	HUS1B	251	Q8NHY5
DLENLLLIKWCVLET	CYP39A1	321	Q9NYL5
EQLAILKSFFLQCQW	HOMEZ	366	Q8IX15
CSVLQSLKELLQNWL	CENPI	491	Q92674
LILLWKVTATGFQQC	DNER	236	Q8NFT8
QWAEFILFSCLLLVI	SLC15A2	671	Q16348
WFQKQAFLILCLLSA	SLC22A1	16	O15245
CALFSTNLDWLVSKL	RYR1	536	P21817
LNSNVLLWLTALAIK	NLGN4X	21	Q8N0W4
LSCLDVWNLKVTEEL	FPGT	511	O14772
ICNSSTNLLLAWLLV	RP1	1121	P56715
TAKCLNIWALILGIL	IFITM1	81	P13164
ILWFNLKEIDFKACL	OR52N1	86	Q8NH53
QVFALLAQETLWDLC	FAM180B	146	Q6P0A1
KLLTWLSVLECVEVF	PEX16	81	Q9Y5Y5
CLKLLLCVQDNTWSI	RNF186	66	Q9NXI6
LISLDKQTCTLFFSW	IGF2R	1626	P11717
CNKIWNALRFILNAL	VARS2	746	Q5ST30
AAELKQWVQLVILSC	THADA	1676	Q6YHU6
LELQDTLALWKCVLT	THADA	1721	Q6YHU6
TLALWKCVLTLLQSE	THADA	1726	Q6YHU6
VFQKIWLTALCLVLV	SLC29A2	286	Q14542
QTLSFLKQEALLSLW	TMEM132E	716	Q6IEE7
LFICQKWLSVDTTLD	PKDREJ	1326	Q9NTG1
LNKISNWTAAIISCL	HCAR3	136	P49019
ELCNLLTNVLFSVTW	NBEAL2	1441	Q6ZNJ1
LQQRWTSFLKAQLLC	SEMA4B	296	Q9NPR2
CKILNAQSLNTWLIL	PIWIL4	476	Q7Z3Z4
NVLLVCLIFWLIFSI	SCN5A	1336	Q14524
TWILTCIYLQLLLFN	KITLG	6	P21583
ILLLTENFLRDTWCN	TICAM2	136	Q86XR7
LAVLTLQIQSLISCW	XBP1	191	P17861
TLTCWIQAALTLKVN	TMEM150C	141	B9EJG8
LTLWFEKCIVETENL	SOS1	831	Q07889
SLALLCQWIQSKLQE	OMA1	366	Q96E52
AWKVNASFLLLLNVV	OMG	421	P23515
WVAKQRILCTLTQSL	SHANK2	81	Q9UPX8
LAKQCQLWDLLSDLE	ABTB1	191	Q969K4
WALALLQCLNLVFLL	CLN3	346	Q13286
DLQDWLFVLLTQLLK	CLASP1	931	Q7Z460
NCAILLFINELELWL	TAS2R1	81	Q9NYW7
CLLLWLSVQNQEFEI	STK31	916	Q9BXU1
FSIECVLYLWSLKIN	PPP3CC	121	P48454
WLKNRTLDEYLTCLL	PRAMEF4	156	O60810
TLDEYLTCLLLWVKQ	PRAMEF4	161	O60810
KNRTLDEYLTCLLLW	PRAMEF6	156	Q5VXH4
VLCQGFLNLLLWDLE	TCP11	291	Q8WWU5
NLTLIWCVVLKLASL	TMC8	371	Q8IU68
CIIWDLNKLSFLTQL	WDFY3	3151	Q8IZQ1
LFLLWLQALQNNCSK	RALGAPA1	131	Q6GYQ0
LWEQCQLLKSTSVFA	VWF	221	P04275
KESASLLWNFIVLLC	SEC16A	1531	O15027
SLTLRTLWEKNCQVL	PLCXD2	196	Q0VAA5
CDLLLSLRTALWQKQ	SREBF2	976	Q12772
KNRTLDEYLTCLLLW	PRAMEF5	156	Q5TYX0
NSLRCELLLVLKTQW	ZNF292	426	O60281
CNLSTLNITLLSWSK	MTERF1	371	Q99551
WLKNRTLDEYLTCLL	PRAMEF11	156	O60813
TLDEYLTCLLLWVKQ	PRAMEF11	161	O60813
LEKWQINLNLFRTCT	GPR65	176	Q8IYL9
LALLVVSLFVFWKLC	SYT10	66	Q6XYQ8
SWKILLFGVINLICT	SLC30A6	31	Q6NXT4
LQVLCLALLWILKST	SLC4A4	956	Q9Y6R1
LILKQALIVVLQWCF	TARBP1	1266	Q13395
ISRDTKNWKIILCLF	TRPM8	686	Q7Z2W7
FILVLCWILNTLVNI	VN1R3	131	Q9BXE9
AWCLLNSLFLILNLS	UBR4	411	Q5T4S7
FSKTQILYVVLWLLC	PTDSS1	376	P48651
NLLVSICIVFLNKWI	SLC35E3	21	Q7Z769
IFRQCFLKLDLNQWL	USP44	296	Q9H0E7
SWNKLCLATLLNTEV	VWA5B1	201	Q5TIE3
QFLLAILWLQLSCVS	TRAV41	6	A0A0B4J266
ILWLQLSCVSAAKNE	TRAV41	11	A0A0B4J266
CFQLWKVVVLAFLAL	TMPPE	81	Q6ZT21
SKNSLCYVLLIWLLT	MTNR1A	141	P48039
TVLFDLEALLKIWCL	NALCN	426	Q8IZF0